Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference ...
Brenden Borrowman, a retired Army veteran, founded Neurova Labs to focus on treating the physiological injury underlying ...
Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following ...
Inside information: Nexstim Plc Agrees on Next Phase of Exclusivity Agreement with Sinaptica Therapeutics, Inc. Nexstim Plc ("Nexstim" or ...
Brainsway ( ($BWAY) ) has provided an announcement. On December 22, 2025, BrainsWay Ltd. reported that Optum Behavioral Health, part of ...
TipRanks on MSN
Nyxoah launches Genio therapy in Netherlands and closes first €22.5 million tranche of convertible notes
Nyxoah ( ($NYXH) ) has issued an update. On December 17, 2025, Nyxoah announced the commercial launch of its Genio hypoglossal neurostimulation ...
Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...
First Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – December 17, 2025, 7:05am CET / 1:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ( ...
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium - Dece ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback